Physician profile
Daniel C Sackman
NPI 1730447731
$2,036.35
in general payments reported to CMS, 2019-2025
19 companies · $796 in 2025
The $796 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2020: $20.08 · 2021: $107 · 2022: $206 · 2024: $311 · 2025: $796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,107.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $306.89 | 2019-2025 | Rezum Generator |
| Intuitive Surgical, INC. | $264.52 | 2019-2025 | |
| Coloplast Corp | $220.58 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $208.29 | 2024-2025 | Gemtesa |
| Astellas Pharma US INC | $197.56 | 2019 | |
| Procept Biorobotics Corporation | $159.92 | 2019-2025 | |
| Urogen Pharma, INC. | $150.20 | 2022 | |
| 180 Medical, INC. | $140.91 | 2019-2025 | Gentlecath |
| Convatec INC. | $91.37 | 2025 | |
| Valencia Technologies Corporation | $79.20 | 2025 | Ecoin Device Kit |
| Antares Pharma, INC. | $44.36 | 2021-2025 | Xyosted |
| Dendreon Pharmaceuticals LLC | $29.63 | 2019 | |
| Myovant Sciences INC. | $27.44 | 2021 | |
| Travere Therapeutics, INC. | $25.23 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $21.93 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $20.08 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $16.99 | 2025 | Bard Urinary Drainage Bag |
| Immunitybio, INC. | $16.08 | 2024 | |
| Merck Sharp & Dohme LLC | $15.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sackman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.